Targeted therapies in breast cancer: New challenges to fight against resistance

DOI: 10.5306/wjco.v8.i2.120

Keywords: Breast cancers, Resistance, Human epidermal growth factor receptor 2, Angiogenesis, Triple negative, Immune tolerance

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text